Checkpoint Therapeutics Announces Presentation of Positive Interim Clinical Results for Anti-PD-L1 Cosibelimab at the European Society for Medical Oncology (ESMO) Congress 2019

by NASDAQ Market News September 30, 2019

NASDAQ Market News
Click here to email author

Global In Vitro Diagnostic Tests Market, 2019-2024 – The Market for IVD Currently Stands at $69.2 Billion

CK Hutchison offers 1.3% of Chi-Med’s share capital aiming to deconsolidate and hold Chi-Med as a strategic investment for the long term

Ads